Please login to the form below

Not currently logged in
Email:
Password:

IFPMA appoints Fumie Griego as assistant director general

She joins the global pharma association from Merck KGaA

Fumie GriegoGlobal pharma association the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has appointed Femie Griego to be its new assistant director general.

She joins from Merck KGaA, where she held senior roles such as head of global oncology policy and strategy, global government affairs policy and has also served as vice president for international health policy at Pharmaceutical Research and Manufacturers of America (PhRMA).

Prior to that Griego spent time at the White House as its senior economist where she provided US officials in both the Bush and Obama administrations with advice on a range of health and policy issues.

Thomas Cueni, director-general at IFPMA, said: “I am delighted to count on the support of Fumie Griego, a highly competent professional, whom I have chosen for her strong pharma expertise and background in global affairs, including intellectual property protection, pricing, costs, value issues and health diplomacy.

“She will be a strong asset to help IFPMA bring thought leadership in addressing global health challenges.”

Griego will join IFPMA's leadership team and will also be working on strengthening the association's work on the industry’s value proposition.

11th May 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

R&D protocol amendments
Rethinking trials: the pros and cons of protocol amendments
Protocol amendments occur often and can be beneficial, but the steps involved can be complex...
Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...

Infographics